S.T. DUPONT (DPT.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:DPT - FR0000054199 - Common Stock

0.0914 EUR

0 (0%)

Last: 1/26/2026, 7:00:00 PM

Fundamental Rating

Overall DPT gets a fundamental rating of 2 out of 10. We evaluated DPT against 52 industry peers in the Textiles, Apparel & Luxury Goods industry. While DPT seems to be doing ok healthwise, there are quite some concerns on its profitability. DPT has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year DPT has reported negative net income.
In the past year DPT had a positive cash flow from operations.
In the past 5 years DPT reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: DPT reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of 1.31%, DPT is not doing good in the industry: 65.38% of the companies in the same industry are doing better.
The Return On Equity of DPT (2.80%) is worse than 65.38% of its industry peers.
The Return On Invested Capital of DPT (0.96%) is worse than 82.69% of its industry peers.

		Industry Rank	Sector Rank
ROA	1.31%
ROE	2.8%
ROIC	0.96%

ROA(3y)-1.58%

ROA(5y)-8.67%

ROE(3y)-59.93%

ROE(5y)-97.15%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Profit Margin value of 1.34%, DPT is not doing good in the industry: 65.38% of the companies in the same industry are doing better.
DPT has a worse Operating Margin (0.81%) than 82.69% of its industry peers.
With a Gross Margin value of 53.62%, DPT is not doing good in the industry: 65.38% of the companies in the same industry are doing better.
DPT's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	0.81%
PM (TTM)	1.34%
GM	53.62%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.87%

GM growth 5Y4.3%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DPT is destroying value.
The number of shares outstanding for DPT remains at a similar level compared to 1 year ago.
The number of shares outstanding for DPT has been increased compared to 5 years ago.
The debt/assets ratio for DPT has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.88 indicates that DPT is not a great score, but indicates only limited risk for bankruptcy at the moment.
DPT has a Altman-Z score of 2.88. This is comparable to the rest of the industry: DPT outperforms 55.77% of its industry peers.
DPT has a debt to FCF ratio of 4.27. This is a neutral value as DPT would need 4.27 years to pay back of all of its debts.
DPT has a Debt to FCF ratio (4.27) which is comparable to the rest of the industry.
DPT has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
DPT has a Debt to Equity ratio of 0.20. This is amongst the best in the industry. DPT outperforms 80.77% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.2
Debt/FCF	4.27
Altman-Z	2.88

ROIC/WACC0.13

WACC7.58%

2.3 Liquidity

DPT has a Current Ratio of 1.53. This is a normal value and indicates that DPT is financially healthy and should not expect problems in meeting its short term obligations.
DPT's Current ratio of 1.53 is in line compared to the rest of the industry. DPT outperforms 59.62% of its industry peers.
DPT has a Quick Ratio of 1.53. This is a bad value and indicates that DPT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.91, DPT perfoms like the industry average, outperforming 57.69% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.53
Quick Ratio	0.91

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

DPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.67%.
Looking at the last year, DPT shows a small growth in Revenue. The Revenue has grown by 5.06% in the last year.
Measured over the past years, DPT shows a small growth in Revenue. The Revenue has been growing by 4.98% on average per year.

EPS 1Y (TTM)-46.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-186.67%

Revenue 1Y (TTM)5.06%

Revenue growth 3Y15.21%

Revenue growth 5Y4.98%

Sales Q2Q%-1.84%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DPT is valued a bit more expensive than 76.92% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DPT is valued a bit more expensive than 61.54% of the companies in the same industry.